Trials
Search / Trial NCT06430008

The Relationship Between Total Sialic Acid and Superoxide Dismutase and the Diagnosis and Prognosis of Lipoid Pneumonia

Launched by HU YINAN · May 21, 2024

Trial Information

Current as of February 19, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Age≥ 18 years old;
  • 2. The diagnosis of lipoid pneumonia must be supported by lung biopsy pathological support or positive oil red O or Sudan staining in bronchoalveolar lavage fluid;
  • 3. Patients with bacterial and fungal pneumonia must be supported by etiological evidence;
  • 4. Patients with cryptogenic organizing pneumonia and pulmonary alveolar proteinosis must be supported by lung biopsy pathology;
  • 5. Patients with lung mucinous adenocarcinoma must be supported by lung tissue biopsy;
  • 6. Lung imaging of patients with pulmonary edema must show paving stone signs;
  • Exclusion Criteria:
  • 1. Age\< 18 years old;
  • 2. The patient only has a history of lipid inhalation and no pathology or positive lipoid staining;
  • 3. Co-infection with the corona virus disease 2019 at the onset of illness;
  • 4. Pregnant

Trial Officials

Yinan Hu

Study Chair

China-Japan Friendship Hospital

About Hu Yinan

Hu Yinan is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on enhancing patient outcomes, the organization specializes in the design, implementation, and management of clinical trials across various therapeutic areas. Leveraging a robust network of healthcare professionals and cutting-edge technologies, Hu Yinan aims to facilitate efficient and ethical research practices. The sponsor is dedicated to fostering collaboration with stakeholders, ensuring compliance with regulatory standards, and prioritizing patient safety throughout the clinical trial process.

Locations

Beijing, Beijing, China

Beijing, Beijing, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0